1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)

C131H135BCl2N8O5P4Pd — CID 158597129

IUPAC1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)
SMILESCC(C)(C)c1cc(-c2cc3ccccc3c(-c3cc(C(C)(C)C)nn3C3CCCCO3)n2)n(C2CCCCO2)n1.CC(C)(C)c1cc(B2OC3(C)CC3(C)O2)n(C2CCCCO2)n1.Clc1cc2ccccc2c(Cl)n1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C33H43N5O2.4C18H15P.C17H27BN2O3.C9H5Cl2N.Pd/c1-32(2,3)27-20-25(37(35-27)29-15-9-11-17-39-29)24-19-22-13-7-8-14-23(22)31(34-24)26-21-28(33(4,5)6)36-38(26)30-16-10-12-18-40-30;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-15(2,3)12-10-13(18-22-16(4)11-17(16,5)23-18)20(19-12)14-8-6-7-9-21-14;10-8-5-6-3-1-2-4-7(6)9(11)12-8;/h7-8,13-14,19-21,29-30H,9-12,15-18H2,1-6H3;4*1-15H;10,14H,6-9,11H2,1-5H3;1-5H;
InChIKeyHVEBQRZGNXLLIQ-UHFFFAOYSA-N
MW2213.61 g/mol
LogP27.82
Rot. Bonds18

About 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)

1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane) (PubChem CID 158597129) has the molecular formula C131H135BCl2N8O5P4Pd and a molecular weight of 2213.61 g/mol. Its IUPAC name is 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane).

Molecular Properties

Compound Name1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)
PubChem CID158597129
Molecular FormulaC131H135BCl2N8O5P4Pd
Molecular Weight2213.61 g/mol
Exact Mass2210.80
IUPAC Name1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)
SMILESCC(C)(C)c1cc(-c2cc3ccccc3c(-c3cc(C(C)(C)C)nn3C3CCCCO3)n2)n(C2CCCCO2)n1.CC(C)(C)c1cc(B2OC3(C)CC3(C)O2)n(C2CCCCO2)n1.Clc1cc2ccccc2c(Cl)n1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C33H43N5O2.4C18H15P.C17H27BN2O3.C9H5Cl2N.Pd/c1-32(2,3)27-20-25(37(35-27)29-15-9-11-17-39-29)24-19-22-13-7-8-14-23(22)31(34-24)26-21-28(33(4,5)6)36-38(26)30-16-10-12-18-40-30;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-15(2,3)12-10-13(18-22-16(4)11-17(16,5)23-18)20(19-12)14-8-6-7-9-21-14;10-8-5-6-3-1-2-4-7(6)9(11)12-8;/h7-8,13-14,19-21,29-30H,9-12,15-18H2,1-6H3;4*1-15H;10,14H,6-9,11H2,1-5H3;1-5H;
InChIKeyHVEBQRZGNXLLIQ-UHFFFAOYSA-N
XLogP27.82
TPSA125.39 Ų
H-Bond Donors
H-Bond Acceptors13
Rotatable Bonds18
Heavy Atoms152
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002213.61
LogP ≤ 527.82
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)?
The IUPAC name of 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane) (CID 158597129) is 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane).
What is the SMILES notation for 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)?
The canonical SMILES for 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane) is CC(C)(C)c1cc(-c2cc3ccccc3c(-c3cc(C(C)(C)C)nn3C3CCCCO3)n2)n(C2CCCCO2)n1.CC(C)(C)c1cc(B2OC3(C)CC3(C)O2)n(C2CCCCO2)n1.Clc1cc2ccccc2c(Cl)n1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.
What is the InChIKey of 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)?
The InChIKey is HVEBQRZGNXLLIQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H43N5O2.4C18H15P.C17H27BN2O3.C9H5Cl2N.Pd/c1-32(2,3)27-20-25(37(35-27)29-15-9-11-17-39-29)24-19-22-13-7-8-14-23(22)31(34-24)26-21-28(33(4,5)6)36-38(26)30-16-10-12-18-40-30;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-15(2,3)12-10-13(18-22-16(4)11-17(16,5)23-18)20(19-12)14-8-6-7-9-21-14;10-8-5-6-3-1-2-4-7(6)9(11)12-8;/h7-8,13-14,19-21,29-30H,9-12,15-18H2,1-6H3;4*1-15H;10,14H,6-9,11H2,1-5H3;1-5H;.
What are the key properties of 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane)?
1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane) has a molecular weight of 2213.61 g/mol, XLogP of 27.82, 18 rotatable bonds, 0 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 1,3-bis[3-tert-butyl-1-(oxan-2-yl)pyrazol-5-yl]isoquinoline;3-tert-butyl-5-(1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexan-3-yl)-1-(oxan-2-yl)pyrazole;1,3-dichloroisoquinoline;palladium;tetrakis(triphenylphosphane) is sourced from PubChem (CID 158597129), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).